Advanced search
Publication Cover
Expert Review of Hematology Volume 7, 2014 - Issue 1: SPECIAL FOCUS: The comprehensive clinical management of multiple myeloma and related plasma-cell disorders. Guest Editors: Paul G Richardson & Joan Bladé
Submit an article Journal homepage
428
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Waldenström macroglobulinemia: from biology to treatment

Ilyas SahinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Houry LeblebjianPharmacy Department, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Steven P TreonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
&
Irene M GhobrialDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USACorrespondenceIrene [email protected]
Pages 157-168 | Published online: 03 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Xin Cao, L. Jeffrey Medeiros, Yi Xia, Xiaoxiao Wang, Sheeba K. Thomas, Sanam Loghavi, Xin Li, Jatin J. Shah, Steven A. Gustafson, Donna M. Weber, Roberto N. Miranda, Zijun Y. Xu-Monette, Robert Z. Orlowski & Ken H. Young. (2016) Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. Leukemia & Lymphoma 57:5, pages 1104-1113.
Read now
Rajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell & Morie A Gertz. (2015) Ibrutinib for the treatment of Waldenström macroglobulinemia. Expert Review of Hematology 8:5, pages 569-579.
Read now
Rajshekhar Chakraborty, Stephen A Ansell, Prashant Kapoor & Morie A Gertz. (2015) Phase II clinical trials for Waldenstrom’s macroglobulinemia. Expert Opinion on Orphan Drugs 3:5, pages 537-547.
Read now
Paul G Richardson & Joan Bladé. (2014) The comprehensive clinical management of multiple myeloma and related-plasma cell disorders. Expert Review of Hematology 7:1, pages 1-3.
Read now

Articles from other publishers (9)

Ava J. Boutilier, Lina Huang & Sherine F. Elsawa. (2022) Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies. International Journal of Molecular Sciences 23:19, pages 11145.
Crossref
Nikistratos Siskos, Chryssa Bekiari, Theophilos Poutahidis, Alexandros Chadras & Anastasia S. Tsingotjidou. (2019) Monitoring Mast Cell Populations in Waldenström’s Macroglobulinemia: A Xenotransplantation Study. Journal of Hematology and Oncology Research 3:3, pages 9-20.
Crossref
Steven H. Swerdlow, Isinsu Kuzu, Ahmet Dogan, Stephan Dirnhofer, John K. C. Chan, Birgitta Sander, German Ott, Luc Xerri, Leticia Quintanilla-Martinez & Elias Campo. (2015) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Archiv 468:3, pages 259-275.
Crossref
I M Ghobrial, R Redd, P Armand, R Banwait, E Boswell, S Chuma, D Huynh, A Sacco, A M Roccaro, A Perilla-Glen, K Noonan, M MacNabb, H Leblebjian, D Warren, P Henrick, J J Castillo, P G Richardson, J Matous, E Weller & S P Treon. (2015) Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia. Leukemia 29:12, pages 2338-2346.
Crossref
Gaetano Romano. (2015) Tumor markers currently utilized in cancer care. Materials and Methods 5.
Crossref
Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y. Lin, Sheeba K. Thomas, Chad C. Bjorklund, Donna M. Weber, Michael Wang, Jatin J. Shah, Xing-Ding Zhang, Richard J. Jones, Stephen M. Ansell, Guang Yang, Steven P. Treon & Robert Z. Orlowski. (2015) Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia. Clinical Cancer Research 21:11, pages 2538-2545.
Crossref
Houry Leblebjian, Kimberly Noonan, Claudia Paba-Prada, Steven P. Treon, Jorge J. Castillo & Irene M. Ghobrial. (2015) Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia. American Journal of Hematology 90:6, pages E122-E123.
Crossref
Adrian Wiestner. (2014) BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma. Hematology 2014:1, pages 125-134.
Crossref
Ilyas Sahin, Feda Azab, Yuji Mishima, Michele Moschetta, Brian Tsang, Siobhan V. Glavey, Salomon Manier, Yu Zhang, Antonio Sacco, Aldo M. Roccaro, Abdel Kareem Azab & Irene M. Ghobrial. (2014) Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib. American Journal of Hematology 89:11, pages 1030-1036.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.